CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 108 filers reported holding CHEMOCENTRYX INC in Q4 2018. The put-call ratio across all filers is 0.95 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2022 | $5,520,000 | +2300.0% | 106,862 | +332.6% | 0.01% | +700.0% |
Q2 2019 | $230,000 | -94.9% | 24,700 | -92.4% | 0.00% | -90.9% |
Q1 2019 | $4,511,000 | +88.0% | 324,748 | +47.6% | 0.01% | +83.3% |
Q4 2018 | $2,400,000 | -9.9% | 220,004 | +4.4% | 0.01% | 0.0% |
Q3 2018 | $2,664,000 | +111.8% | 210,762 | +120.7% | 0.01% | +100.0% |
Q2 2018 | $1,258,000 | +170.5% | 95,494 | +179.1% | 0.00% | +200.0% |
Q1 2018 | $465,000 | +200.0% | 34,216 | +31.5% | 0.00% | – |
Q4 2017 | $155,000 | +15.7% | 26,016 | +44.5% | 0.00% | – |
Q3 2017 | $134,000 | – | 17,999 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tri Locum Partners LP | 296,327 | $7,429,000 | 2.90% |
Integral Health Asset Management, LLC | 400,000 | $10,028,000 | 2.61% |
Cormorant Asset Management, LP | 865,000 | $21,686,000 | 1.66% |
HealthCor Management, L.P. | 956,740 | $23,985,000 | 1.60% |
Sofinnova Investments, Inc. | 573,684 | $14,382,000 | 1.09% |
Lisanti Capital Growth, LLC | 321,569 | $8,062,000 | 0.91% |
Cahill Wealth Management, LLC | 44,913 | $1,125,000 | 0.84% |
Perceptive Advisors | 1,655,079 | $41,493,000 | 0.83% |
RA Capital Management | 1,155,964 | $28,980,000 | 0.63% |
Avidity Partners Management LP | 1,175,000 | $29,457,000 | 0.61% |